 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business...

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

This is a Bullish indicator signaling ANIX's price could rise from here. Traders may explore going long the stock or buying call options...

Anixa Biosciences (ANIX, $3.69) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 15, 2024

This is a signal that ANIX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Anixa Biosciences (ANIX, $3.69) RSI Indicator left the oversold zone on March 15, 2024

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor...

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Recap: Anixa Biosciences Q1 Earnings

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress PR Newswire SAN JOSE, Calif., March 11...

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

Anixa Biosciences (ANIX, $3.22) RSI Indicator left the oversold zone on March 08, 2024

This price move could be a signal that ANIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

Anixa Biosciences (ANIX, $3.22) price may climb as it broke lower Bollinger Band on Mar 08, 2024

This is a signal that ANIX's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Anixa Biosciences (ANIX, $3.45) Stochastic Oscillator left the oversold zone on March 07, 2024

UBS Group AG trimmed its position in shares of Anixa Biosciences, Inc. (NASDAQ:ANIX  Free Report) by 4.7% during the third quarter, according to the company in its most recent Form 13F filing...

UBS Group AG Sells 29,840 Shares of Anixa Biosciences, Inc. (NASDAQ:ANIX)

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Volume (M)	32,692.00
52-Wk High	$5.13
52-Wk Low	$2.75

ANIX Anixa Biosciences Inc

About

Feed

News

Earnings

Fundamentals